HDAC2 levels are increased in NPC disease models.
c-Abl inhibition prevents the increase of HDAC2 in NPC disease models.
Cholesterol and oxidative stress are upstream regulators of the c-Abl/HDAC2 pathway.
c-Abl inhibition prevents the HDAC2-dependent gene repression in NPC models.